Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106956158 | 10695615 | 8 | F | 201506 | 20160926 | 20150107 | 20160930 | EXP | US-PFIZER INC-2015004178 | PFIZER | 76.00 | YR | F | Y | 44.90000 | KG | 20160930 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 106956158 | 10695615 | 1 | PS | LYRICA | PREGABALIN | 1 | Oral | 25 MG, UNK | N | 21446 | 25 | MG | CAPSULE, HARD | ||||||
| 106956158 | 10695615 | 2 | SS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, 3X/DAY | N | 21446 | 300 | MG | CAPSULE, HARD | TID | |||||
| 106956158 | 10695615 | 3 | SS | LYRICA | PREGABALIN | 1 | Oral | 300 MG, 3X/DAY | N | M22778 | 21446 | 300 | MG | CAPSULE, HARD | TID | ||||
| 106956158 | 10695615 | 4 | SS | LYRICA | PREGABALIN | 1 | UNK, 2X/DAY | N | 21446 | CAPSULE, HARD | BID | ||||||||
| 106956158 | 10695615 | 5 | C | LASIX | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 106956158 | 10695615 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 106956158 | 10695615 | 7 | C | DIAZEPAM. | DIAZEPAM | 1 | 10 MG, DAILY | 0 | 10 | MG | |||||||||
| 106956158 | 10695615 | 8 | C | AMBIEN | ZOLPIDEM TARTRATE | 1 | UNK | 0 | |||||||||||
| 106956158 | 10695615 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, 2X/DAY | 0 | 20 | MG | CAPSULE | BID | ||||||
| 106956158 | 10695615 | 10 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 125 UG, 1X/DAY | 0 | 125 | UG | TABLET | QD | ||||||
| 106956158 | 10695615 | 11 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 106956158 | 10695615 | 12 | C | VERAPAMIL | VERAPAMIL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 106956158 | 10695615 | 13 | C | TRIAMTERENE. | TRIAMTERENE | 1 | Oral | 37.5-25MG CT ONE CAPSULE | 0 | 1 | DF | CAPSULE | |||||||
| 106956158 | 10695615 | 14 | C | HYDROXYZINE HCL | HYDROXYZINE HYDROCHLORIDE | 1 | Oral | 25 MG, THREE TIMES A DAY AS NEEDED | 0 | 25 | MG | TABLET | |||||||
| 106956158 | 10695615 | 15 | C | ONE A DAY | 2 | ONE ONCE A DAY | 0 | 1 | DF | QD | |||||||||
| 106956158 | 10695615 | 16 | C | FISH OIL | FISH OIL | 1 | Oral | 1000 MG, 1X/DAY | 0 | 1000 | MG | CAPSULE | QD | ||||||
| 106956158 | 10695615 | 17 | C | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 106956158 | 10695615 | 18 | C | BONIVA | IBANDRONATE SODIUM | 1 | UNK | 0 | |||||||||||
| 106956158 | 10695615 | 19 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 106956158 | 10695615 | 1 | Neuropathy peripheral |
| 106956158 | 10695615 | 2 | Fibromyalgia |
| 106956158 | 10695615 | 3 | Neuroma |
| 106956158 | 10695615 | 8 | Sleep disorder |
| 106956158 | 10695615 | 9 | Gastric disorder |
| 106956158 | 10695615 | 10 | Atrial fibrillation |
| 106956158 | 10695615 | 11 | Migraine |
| 106956158 | 10695615 | 12 | Blood pressure abnormal |
| 106956158 | 10695615 | 14 | Pruritus |
| 106956158 | 10695615 | 15 | Supplementation therapy |
| 106956158 | 10695615 | 16 | Routine health maintenance |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 106956158 | 10695615 | OT |
| 106956158 | 10695615 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 106956158 | 10695615 | Animal bite | |
| 106956158 | 10695615 | Anxiety | |
| 106956158 | 10695615 | Blood glucose increased | |
| 106956158 | 10695615 | Blood pressure decreased | |
| 106956158 | 10695615 | Depressed mood | |
| 106956158 | 10695615 | Drug ineffective | |
| 106956158 | 10695615 | Dysstasia | |
| 106956158 | 10695615 | Fall | |
| 106956158 | 10695615 | Fractured coccyx | |
| 106956158 | 10695615 | Gait disturbance | |
| 106956158 | 10695615 | Hypoaesthesia | |
| 106956158 | 10695615 | Intentional product use issue | |
| 106956158 | 10695615 | Limb injury | |
| 106956158 | 10695615 | Loss of consciousness | |
| 106956158 | 10695615 | Lyme disease | |
| 106956158 | 10695615 | Malaise | |
| 106956158 | 10695615 | Middle insomnia | |
| 106956158 | 10695615 | Mobility decreased | |
| 106956158 | 10695615 | Neuroma | |
| 106956158 | 10695615 | Overdose | |
| 106956158 | 10695615 | Pain in extremity | |
| 106956158 | 10695615 | Peripheral coldness | |
| 106956158 | 10695615 | Renal disorder | |
| 106956158 | 10695615 | Shock | |
| 106956158 | 10695615 | Stress | |
| 106956158 | 10695615 | Vomiting | |
| 106956158 | 10695615 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |